[IGF-1, IGFBP-3, PICP, ICTP].
Ito
Takaaki
T
Department of Urology, Tokyo Medical University.
Yamamoto
Shinya
S
D000818:Animals; D014408:Biomarkers, Tumor / Q000032:analysis*; D001859:Bone Neoplasms / Q000175:diagnosis / Q000556:secondary; D024042:Collagen Type I; D016001:Confidence Intervals; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000032:analysis*; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D008297:Male; D010446:Peptide Fragments / Q000032:analysis*; D010455:Peptides; D011237:Predictive Value of Tests; D011347:Procollagen / Q000032:analysis*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000473:pathology; D012680:Sensitivity and Specificity
D014408:Biomarkers, Tumor; D024042:Collagen Type I; D018972:Insulin-Like Growth Factor Binding Protein 3; D010446:Peptide Fragments; D010455:Peptides; D011347:Procollagen; C052929:collagen type I trimeric cross-linked peptide; C042813:procollagen type I carboxy terminal peptide; D007334:Insulin-Like Growth Factor I